The Claim
In adults undergoing radioactive iodine therapy for hyperthyroidism, each additional year of age is associated with a 4.3% reduction in the odds of clinical improvement (OR=0.957, p=0.025).
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Among adults treated with radioactive iodine for an overactive thyroid, older patients are less likely to show clinical improvement than younger patients, with each year of age reducing the chance of improvement by about 4.3%.
See the scientific wording
In adults undergoing radioactive iodine therapy for hyperthyroidism, older age is associated with reduced likelihood of clinical improvement, with each additional year of age reducing the odds of positive outcome by approximately 4.3% (OR=0.957, p=0.025), suggesting age may influence treatment response through metabolic or physiological factors.
As people get older, their kidneys clear radioactive iodine from the blood more slowly, which means the radiation doesn't stay in the body long enough to destroy enough thyroid tissue, so the thyroid keeps producing too much hormone.
What the research says
1 studyThis study found that older adults taking radioactive iodine for an overactive thyroid are slightly less likely to get better than younger adults — each year older reduces the chance of success a little bit, which matches what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.